Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment-6

<p><b>Copyright information:</b></p><p>Taken from "Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment"</p><p>http://www.molecularneurodegeneration.com/content/2/1/20</p><p>Molecular Neurodegeneration 2007;2():20-20.</p><p>Published online 22 Oct 2007</p><p>PMCID:PMC2214725.</p><p></p>, 6 times a week and age-matched control mice (n = 5) received vehicle. At the end of the treatment total RNA was isolated from cortices and hippocampi and mRNA expression of indicated genes determined by RT-QPCR. Values are means ± SEM and represent fold of change compared to vehicle treatment (two-tailed Student's test)